LIFEMD, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.3 USD | +4.31% |
|
+0.68% | +24.13% |
| Mar. 12 | Craig-Hallum Adjusts LifeMD's Price Target to $15 From $10, Maintains Buy Rating | MT |
| Mar. 12 | Cantor Fitzgerald Adjusts Price Target on LifeMD to $11 From $9, Maintains Overweight Rating | MT |
Financials (USD)
| Sales 2024 * | 201M | Sales 2025 * | 244M | Capitalization | 398M |
|---|---|---|---|---|---|
| Net income 2024 * | -9M | Net income 2025 * | -8M | EV / Sales 2024 * | 1.98 x |
| Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.63 x |
| P/E ratio 2024 * |
-22.8
x | P/E ratio 2025 * |
-42.5
x | Employees | 209 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.99% |
More Fundamentals
* Assessed data
More news
Latest transcript on LifeMD, Inc.
More recommendations
More press releases
| 1 day | -0.50% | ||
| 1 week | +0.10% | ||
| Current month | -3.99% | ||
| 1 month | -2.08% | ||
| 3 months | +66.16% | ||
| 6 months | +45.79% | ||
| Current year | +19.06% |
1 week
9.22
10.25
1 month
9.2212.01
Current year
5.0012.01
1 year
1.4012.01
3 years
1.1416.28
5 years
0.4233.02
10 years
0.1533.02
| Managers | Title | Age | Since |
|---|---|---|---|
Justin Schreiber
CEO | Chief Executive Officer | 40 | - |
Marc Benathen
DFI | Director of Finance/CFO | 43 | 21-02-28 |
Dennis Wijnker
CTO | Chief Tech/Sci/R&D Officer | 47 | 21-12-12 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Will Febbo
BRD | Director/Board Member | 55 | 23-06-19 |
Naveen Bhatia
BRD | Director/Board Member | 43 | 21-09-07 |
John Strawn
BRD | Director/Board Member | 62 | 11-06-30 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.46% | 4 M€ | -5.15% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 10.29 | +4.26% | 171 358 |
| 24-04-17 | 9.87 | -0.50% | 488,662 |
| 24-04-16 | 9.92 | +3.23% | 426,844 |
| 24-04-15 | 9.61 | -0.52% | 447,996 |
| 24-04-12 | 9.66 | -5.48% | 762,118 |
Delayed Quote Nasdaq, April 17, 2024 at 04:00 pm EDT
More quotes
LifeMD, Inc. is a direct-to-patient telehealth company, which provides comprehensive virtual and in-home healthcare. The Company operates through two segments: Telehealth and WorkSimpli. Telehealth segment is engaged in telehealth platform, which integrates a clinician-centric electronic medical record (EMR) system, algorithms for case-load balancing and scheduling, customer relationship management functionality, asynchronous communication, secure synchronous, cloud pharmacy and more. Its technology platform, combined with its 50-state affiliated provider network, enables the management of virtual treatment offerings across various health conditions, including, dermatology, urgent and primary care, chronic care management, dermatology, chronic care management and other. Its WorkSimpli segment offers workplace and document services. This segment offers PDFSimpli an online software as a service platform that allows users to create, edit, convert, sign and share PDF documents.
Calendar
2024-05-09
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
9.87
USD
Average target price
12.6
USD
Spread / Average Target
+27.66%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +19.06% | 398M | |
| +3.47% | 32.15B | |
| +6.53% | 6.72B | |
| +15.28% | 3.68B | |
| -10.26% | 3.38B | |
| -30.19% | 1.21B | |
| -38.71% | 1.04B | |
| -0.11% | 893M | |
| -28.03% | 813M | |
| -41.53% | 817M |
- Stock Market
- Equities
- LFMD Stock
